{Reference Type}: Journal Article
{Title}: Antiemetic Guidelines: Using Education to Improve Adherence and Reduce Incidence of CINV in Patients Receiving Highly Emetogenic Chemotherapy.
{Author}: Mellin C;Lexa M;Leak Bryant A;Mason S;Mayer DK;
{Journal}: Clin J Oncol Nurs
{Volume}: 22
{Issue}: 3
{Year}: 06 2018 1
{Factor}: 1.283
{DOI}: 10.1188/18.CJON.297-303
{Abstract}: With the development of increasingly effective antiemetic regimens, guideline adherence can prevent 70%-80% of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.<BR>This quality improvement project aims to increase rates of adherence to national guidelines and, ultimately, decrease rates of CINV experienced by patients receiving highly emetogenic chemotherapy.<BR>A retrospective chart analysis was performed. In-person education was provided to staff nurses and advanced practice providers on guidelines, followed by a survey immediately postintervention and again at three months.<BR>Prior to the intervention, 49% of patients were found to experience CINV, with only 7% receiving guideline-appropriate prophylaxis. At three months, 37% of patients experienced CINV, with 22% receiving appropriate prophylaxis.